Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is IVABRADINE HYDROCHLORIDE, with a corresponding US DMF Number 33107.
Remarkably, this DMF maintains an Active status since its submission on October 31, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 29, 2019, and payment made on November 26, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II